Cargando…
Increased Prevalence of Myocardial Injury in Patients with SARS-CoV-2 Viremia
BACKGROUND: Patients with coronavirus disease 2019 (COVID-19) have a high prevalence of detectable troponin and myocardial injury. In addition, a subset of patients with COVID-19 has detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral loads. The objective of this study was...
Autores principales: | Siddiqi, Hasan K., Weber, Brittany, Zhou, Guohai, Regan, James, Fajnzylber, Jesse, Coxen, Kendyll, Corry, Heather, Yu, Xu G., DiCarli, Marcelo, Li, Jonathan Z., Bhatt, Deepak L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654293/ https://www.ncbi.nlm.nih.gov/pubmed/33181107 http://dx.doi.org/10.1016/j.amjmed.2020.09.046 |
Ejemplares similares
-
Viral Load Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospitalized Individuals With Coronavirus Disease 2019
por: Regan, James, et al.
Publicado: (2021) -
Liver Fibrosis Index FIB‐4 Is Associated With Mortality in COVID‐19
por: Li, Yijia, et al.
Publicado: (2020) -
No Significant Changes to Residual Viremia After Switch to Dolutegravir and Lamivudine in a Randomized Trial
por: Li, Jonathan Z, et al.
Publicado: (2019) -
RELATIONSHIPS BETWEEN MYOCARDIAL INJURY, INDEX HOSPITALIZATION CHARACTERISTICS, AND LONGER-TERM OUTCOMES IN SARS-COV-2 INFECTION
por: Weber, Brittany, et al.
Publicado: (2021) -
Impact of Interleukin-6 Receptor Blockade With Tocilizumab on Cardiac Injury in Patients With COVID-19: A Retrospective Cohort Study
por: Weber, Brittany N, et al.
Publicado: (2021)